Shannon MuiseThe Problem with SulfonylureasStarting their marketing debut in the 1950s, sulfonylureas have been widely used throughout the world. Compared to its pricey competitors…Apr 29, 2020Apr 29, 2020
Shannon MuiseThe Controversial Nature of Diet SodaIs diet soda healthy or dangerous?Apr 15, 2020Apr 15, 2020
Shannon MuiseWhy is insulin so expensive?Why rising costs is leading to declining healthApr 15, 2020Apr 15, 2020
Shannon MuiseHow the New Oral GLP-1 Agonist Compares to Other Anti-diabetic MedicationThe FDA approved the first oral glucagon-like peptide-1 (GLP-1) agonist Rybelsus (Semaglutide) on September 20, 2019, after several…Apr 8, 2020Apr 8, 2020